期刊文献+

利用反向遗传操作技术拯救重组新城疫病毒 被引量:2

Rescue of recombinant Newcastle disease virus by reverse genetic system
下载PDF
导出
摘要 将新城疫病毒(Newcastle disease virus,NDV)Anhinga株的全长cDNA的克隆质粒以及L、P、NP的表达质粒共转染稳定表达T7 RNA聚合酶的BSRT7/5细胞,得到拯救病毒。通过RT-PCR扩增、酶切鉴定、测序验证拯救病毒中分子标签的存在,并通过血凝试验测定病毒的血凝效价、测定蚀斑形成单位确定病毒滴度,从而证明病毒拯救成功。新城疫病毒Anhinga株的拯救成功为该病毒进行结构基因研究和疫苗研制奠定了基础。 The plasmid of the full-length Newcastle disease virus (NDV) cDNA from Anhinga strain was cotransfected with helper plasmids encoding viral nucleoprotein, phosphoprotein and large polymerase protein into BSR T7/5 cells stably expressing T7 RNA polymerase. The virus was rescued and amplified by inoculation of the supernatant from the transfected cells into the allantoic cavity of specific-pathogen free chicken embryos. By RT-PCR amplification, restriction enzyme digestion and sequencing confirmation, it identified the unique molecular tag of the rescued virus. Virus HA titer was also measured through the hemagglutination test (HA test), and determined viral titers by plaque-forming units. Thus, it concluded that the virus was rescued successfully from cDNA. The successful rescue of NDV Anhinga strain established a useful platform for the further study of NDV and development of recombinant vaccines.
出处 《东北农业大学学报》 CAS CSCD 北大核心 2010年第10期73-77,共5页 Journal of Northeast Agricultural University
基金 哈尔滨市科技创新人才发展计划资助项目(2006RFXXS002)
关键词 新城疫病毒 病毒拯救 共转染 反向遗传操作系统 Newcastle disease virus virus rescue cotransfection reverse genetic manipulation system
  • 相关文献

参考文献10

  • 1Krishnamurthy S, Samal S K. Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence[J]. Gen Virol, 1998, 79: 2419-2424.
  • 2Phillips R J, Samson A C, Emmerson P T. Nucleotide sequence of the 5"-terminus of Newcastle disease virus and assembly of the complete genomic sequence: Agreement with the "rule of six" [J]. Arch Virol, 1998, 143: 1993-2002.
  • 3Peeples M E. Newcastle disease virus replication [D]. Dordrecht, The Netherlands: Kluwer Aca-demic, 1988: 45-78.
  • 4Steward M, Vipond I B, Milla r N S, et al. RNA editing in Newcastle disease virus[J]. Gen Virol, 1993, 74: 2539-2547.
  • 5Peeters B P, de Leeuw O S, Koch G, et al. Rescue of Newcastle disease virus from cloned cDNA: Evidence that cleavability of the fusion protein is a major determinant for virulence[J]. Virol, 1999, 73: 5001-5009.
  • 6Romer-Oberdorfer A, Mundt E, Mebatsion T, et al. Generation of recombinant lentogenic Newcastle disease virus from cDNA[J]. Gen Virol, 1999, 80(11): 2987-2995.
  • 7Estevez C, King D, Yu Q. et al. Evaluation of Newcastle disease vires chimeras expressing the emagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic ecombinant virus backbone [J]. Virus Res, 2007, 129(2): 182-190.
  • 8葛金英,温志远,高宏雷,王永,胡森,鲍恩东,王笑梅,步志高.表达传染性法氏囊病毒超强毒流行株VP2基因重组新城疫病毒LaSota疫苗株的构建[J].中国农业科学,2008,41(1):243-251. 被引量:11
  • 9白志坤,冯新畅.DNA疫苗免疫机制及预防新城疫病毒的研究进展[J].东北农业大学学报,2007,38(3):416-419. 被引量:3
  • 10Zorn U, Dallmann I, Grosse J, et al. Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus[J]. Cancer Biother, 1994, 9(3): 225-235.

二级参考文献34

  • 1顾惠明,侯绍华,裘孝良,陈燕军,郝勤宗,潘饶霖,赵本进,王权,刘金明.新城疫热稳定性天然弱毒B95株核酸疫苗的构建[J].中国兽医科技,2004,34(8):39-44. 被引量:6
  • 2Wolff J A,Malone R W,Williams P,et al.Direct gene transfer intomouse muscle in vivo[J].Science,1990,247:1465-1468.
  • 3Spier R E.Nucleic acid vaccines[J].Vaccine,1995,13(1):131-132.
  • 4Oshop,G L,Elankumaran S.In vovo delivery of DNA to the avian embryo[J].Vaccine,2003,21,1275-1281.
  • 5Srivastava I K,Liu A M.Gene vaccines[J].Ann Intern Med,2003,138:550-559.
  • 6Robinson H L,Hunt L A,Webster R G.Protection against a lethal influenza virus challenge by immunization with a heamagglutininexpressing plasmid DNA[J].Vaccine,1993,11:957-960.
  • 7Cox G J,Lamb T J,Babiuk L A.Bovine herpesvirus-1:Immune response in mice and cattle injected with plasmid DNA[J].J Virol,1993,67:5664-5667.
  • 8Hosie M T,Flynn J N,Rigby M A,et al.DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antibodies[J].Virol,1998,72:7310-7319.
  • 9Sakaguchi M,Nakamura H,Sonoda K F,et al.Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus[J].Vaccine,1996,14:747-752.
  • 10Heckert R A,Elankumaran S,Oshop G L,et al.A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization[J].Vet Immunol Immunopathol,2002,89(1-2):67-81.

共引文献12

同被引文献62

  • 1李新生,闫若潜,陈红英,郝慧芳,夏春.新城疫病毒作为疫苗载体的研究进展[J].动物医学进展,2005,26(4):1-5. 被引量:2
  • 2胡顺林,张艳梅,孙庆,刘玉良,吴艳涛,刘秀梵.鹅源新城疫病毒拯救体系的建立[J].微生物学通报,2007,34(3):426-429. 被引量:6
  • 3Nakaya T, Cros J, Park MS, et al. Recombinant Newcastle disease virus as a vaccine vector. Virology, 2001, 75(23): 11868-11873.
  • 4Vigil A, Park MS, Garcia-Sastre A, et al. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res, 2007, 67(17): 8285-8292.
  • 5Janke M, Peeters B, Schirrmacher V, et al. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy. Gene Ther, 2007, 14(23): 1639-1649.
  • 6Heng Z, Markus J, Volker S, et al. Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy. Virus Res, 2008, 136(1/2): 75-80.
  • 7Piihler F, Willuda J, Beier R, et al. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes. Gene Ther, 2008, 15(5): 371 383.
  • 8Vigil A, Martinez O, Garcia-Sastre A, et al. Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther, 2008, 16(11): 1883-1890.
  • 9Zamarin D, Vigil A, Fong Y, et al. Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther, 2009, 16(6): 796-804.
  • 10Zamarin D, Martinez-Sobrido L, Fong Y, et al. Enhancement of oncolytic properties of recombinant Newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther, 2009, 17(4): 697-706.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部